Home › NDC Lookup › Ingredients › Glycerin, Naphazoline Hcl › 55910-0870-01
DG Maximum Strength Redness Relief glycerin, naphazoline HCl .5 g/100mL; .03 g/100mL Solution — NDC 55910-0870-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

DG Maximum Strength Redness Relief glycerin, naphazoline HCl .5 g/100mL; .03 g/100mL Solution — NDC 55910-870-01 (Billing 55910-0870-01)

by Dolgencorp, Inc · 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER

This is a package of DG Maximum Strength Redness Relief glycerin, naphazoline HCl .5 g/100mL; .03 g/100mL Solution from Dolgencorp, Inc, marketed since Jan 2020 and currently FDA-listed. It is this product's only package size.

NDC 55910-0870-01
🏷️ FDA NDC (as labeled) 55910-870-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 55910-870-01
Product NDC 55910-870
11-digit billing NDC 55910087001
RxCUI 1235200
UNII PDC6A3C0OX, MZ1131787D
UPC 0095072057557
Application # M018
SPL Set ID 9cb261ed-b708-1189-e053-2a95a90a547d
Established class (EPC) Non-Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-01-31
Route OPHTHALMIC
Dosage form SOLUTION
Substance GLYCERIN; NAPHAZOLINE HYDROCHLORIDE
Quick answers
  • RxCUI (RxNorm): 1235200
Why two NDCs? The FDA registers this code as 55910-870-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 55910-0870-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Non-Standardized Chemical Allergen class.

Pharmacologic class Non-Standardized Chemical Allergen
Drug family (ATC) Enemas, Other drugs for constipation
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

DG Maximum Strength Redness Relief is an over-the-counter eye drop solution marketed under FDA's OTC monograph rules for ophthalmic decongestants. It contains naphazoline hydrochloride, a decongestant typically used to reduce redness and minor eye irritation caused by allergens or fatigue, and glycerin, a lubricant commonly included to soothe and moisturize the eye surface. This product is applied directly to the eyes as needed for temporary relief of these symptoms.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
55910-0870-01 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER 2020-01-31 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Walgreens Eye Drops Maximum Redness Relief 15mL .03 g/100mL; .5 g/100mL 00363-4546-01 Walgreen 1 bottle — — FDA listed —
Target Eye Drops Maximum Redness Relief Eye 500 mg/100mL; 30 mg/100mL 11673-0100-01 Target 1 bottle — — FDA listed —
Topcare Maximum Redness Relief Eye Drops .5 g/100mL; .03 g/100mL 36800-0975-01 Topco 1 bottle — — FDA listed —
Meijer Maximum Redness Relief and Lubricant .03 g/100mL; .5 g/100mL 41250-0715-01 Meijer 1 bottle — — FDA listed —
GoodSense Redness Relief Plus .03 g/100mL; .5 g/100mL 50804-0150-01 Geiss, 1 bottle — — FDA listed —
CVS Maximum Redness Relief .03 g/100mL; .5 g/100mL 51316-0837-01 CVS 1 bottle — — FDA listed —
Exchange Select Maximum Redness Relief Eye Drops .5 g/100mL; .03 g/100mL 55301-0998-01 Army 1 bottle — — FDA listed —
Family Wellness Maximum Redness Relief Eye Drops .5 g/100mL; .03 g/100mL 55319-0909-01 Family 1 bottle — — FDA listed —
Medics Choice Eye Drops Maximum Redness Relief .5 g/100mL; .03 g/100mL 55651-0059-01 K.C. 1 bottle — — FDA listed —
DG Maximum Strength Redness Relief .5 g/100mL; .03 g/100mLthis 55910-0870-01 Dolgencorp, 1 bottle — — FDA listed —
Winco Maximum Redness Relief Eye Drops 500 mg/100mL; 30 mg/100mL 67091-0285-15 WinCo 1 bottle — — FDA listed —
Clear Eyes Cooling Redness Relief .3 mg/mL; 5 mg/mL 67172-0393-01 Prestige 1 bottle — — FDA listed —
Clear Eyes Maximum Redness Relief .3 mg/mL; 5 mg/mL 67172-0696-01 Prestige 1 bottle — — FDA listed —
Harris Teeter Eye Drops Maximum Redness Relief .5 g/100mL; .03 g/100mL 69256-0058-01 Harris 1 bottle — — FDA listed —
CareOne Maximum Redness Relief Eye Drops .5 g/100mL; .03 g/100mL 72476-0012-01 Retail 1 bottle — — FDA listed —
Tyson 2.0 Mike Red Eye Drops For Dry High Eyes .5 g/100mL; .03 g/100mL 84843-0050-01 Jbrands 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Jan 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII F5UM2KM3W7
    Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
  • UNII R57ZHV85D4
    Boric acid is a weak acid derived from boron. In medicines, it typically serves as a buffer to help maintain the product's pH level and may act as a preservative in certain formulations.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 91MBZ8H3QO
    Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDolgencorp, Inc
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code55910
First marketedJan 2020
Product typeHuman Otc Drug
Portfolio3 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 41 words ▾

Uses For the relief of redness of the eye due to minor eye irritations For the temporary relief of burning and irritation due to dryness of the eye For use as a protectant against further irritation or dryness of the eye

⏱️ Dosage and Administration 15 words ▾

Directions Instill 1 or 2 drops in the affected eye(s) up to 4 times daily.

⚠️ Warnings 113 words ▾

Warnings For external use only Do not use if solution changes color or becomes cloudy Ask a doctor before use if you have narrow angle glaucoma When using this product To avoid contamination, do not touch tip of container to any surface Replace cap after using Overuse may produce increased redness of the eye Pupils may become enlarged temporarily Stop use and ask a doctor if you experience eye pain you experience changes in vision you experience continued redness or irritation of the eye the condition worsens or persists for more than 72 hours Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 7 words ▾

Active ingredients Glycerin 0.5% Naphazoline hydrochloride 0.03%

🧪 Inactive Ingredients 12 words ▾

Inactive ingredients benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

🎯 Purpose 7 words ▾

Purposes Glycerin ----Lubricant Naphazoline hydrochloride ----Redness reliever

📄 Do Not Use 10 words ▾

Do not use if solution changes color or becomes cloudy

📄 Ask a Doctor Before Use If 11 words ▾

Ask a doctor before use if you have narrow angle glaucoma

📄 When Using This Product 33 words ▾

When using this product To avoid contamination, do not touch tip of container to any surface Replace cap after using Overuse may produce increased redness of the eye Pupils may become enlarged temporarily

📄 Stop Use and Ask a Doctor If 35 words ▾

Stop use and ask a doctor if you experience eye pain you experience changes in vision you experience continued redness or irritation of the eye the condition worsens or persists for more than 72 hours

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 25 words ▾

Other information store at room temperature remove contact lenses before using Tamper Evident: Do not use this product if imprinted neckband is missing or broken.

📄 Package Label / Principal Display Panel 2 words ▾

Package Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Glycerin, naphazoline HCl — the ingredient across all brands.

Top reported reactions

Hordeolum1

Reporter sex

1 reports
Female · 100%
Reports over time (by year) — tap or hover for the count & year
2023 2024 2025 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Dolgencorp, Inc. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Dolgencorp, Inc is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 55910-0867-26 · Dolgencorp 55910-0871-38 · Old →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.